Transforming growth factor-β1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system
- 26 August 2003
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 291 (1) , 1-10
- https://doi.org/10.1016/s0014-4827(03)00336-7
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Matrix-directed regulation of pericellular proteolysis and tumor progressionSeminars in Cancer Biology, 2002
- Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targetsInternational Journal of Cancer, 2002
- TGF-?-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator systemInternational Journal of Cancer, 2001
- TNF-α stimulates activation of pro-MMP2 in human skin through NF-κB mediated induction of MT1-MMPJournal of Cell Science, 2001
- Matrix Metalloproteinases in Human MelanomaJournal of Investigative Dermatology, 2000
- The plasminogen activation system in tumor growth, invasion, and metastasisCellular and Molecular Life Sciences, 2000
- A Cell Binding Domain from the α3 Chain of Type IV Collagen Inhibits Proliferation of Melanoma CellsJournal of Biological Chemistry, 1997
- In situ expression of transforming growth factor ?? is associated with melanoma progression and correlates with Ki67, HLA-DR and ?? 3 integrin expressionMelanoma Research, 1997
- The urokinase-type plasminogen activator system in cancer metastasis: A reviewInternational Journal of Cancer, 1997
- The plasminogen activation system in melanoma cell lines and in melanocytic lesionsMelanoma Research, 1996